NR4A1 and breast cancer: BC is generally subdivided into four distinct subtypes according to the expression of hormone receptors (HR; estrogen receptor (ER) and progesterone receptor (PgR)) and human epidermal growth factor receptor-2 (HER2): HR+/HER2−, HR+/HER2+, HR/HER2+ and triple-negative BC.